11 |
A whole cord model for the identification of mechanisms for the antivascular effects of DMXAAMoses, Kiriana Mihi January 2007 (has links)
Endothelial cells form the inner lining of a blood vessel and their structure and functional integrity are important in maintenance of the vessel wall and circulatory function. These cells play key roles in immune and inflammatory reactions by regulating lymphocyte and leukocyte movement into tissues; they are also main targets for antivascular agents in cancer therapy. Endothelial cell responses to different stimuli have been previously investigated using conventional approaches, 'HUVEC in vitro culture system'. In this study an ex vivo perfusion model was constructed and utilized using whole human umbilical cords, in attempts to replicate a more accurate in vivo microenvironment. Assessment of the proportion and duration of endothelial cell viability in the ex vivo model was undertaken using a MTT 3, (4,5-dimethylthiazol-2-yl) 2, 5-diphenyl-tetrazolium bromide viability assay. A time baseline was successfully established for all experimental perfusions. Endothelial cell immune response was assessed through intravenous perfusion of the endotoxin, Lipopolysaccharide (LPS). Gene expression profiles revealed a significant increase in expression levels of E-Selctin (E-Sel), Intracellular adhesion molecule (I-CAM) and Tissue Factor (TF) relative to the housekeeping gene Beta 2 Microglobulin. When LPS was administered in combination with Hypertonic Saline Solution (HSS), expression levels declined indicating HSS interferes with the activation pathway of LPS ultimately suppressing its effectiveness on endothelial cells. HSS impact was also recognized from perfusion experiments on resting endothelial cells. All identified genes were suppressed by HSS apart from inducible nitric oxide synthase (iNOS). As a potential target for antivascular agents, HUVEC were then stimulated with DMXAA and gene responses of Tumour Necrosis Factor-α (TNF-α) was analysed. DMXAA demonstrates excellent antivascular acivity in experimental tumours, so tumour conditioned media (TCM) was administered intravenously through umbilical cord segments to replicate a tumour microenvironment prior to DMXAA addition. When cells were stimulated with Tumour conditioned media then administered DMXAA, TNF-α expression was significantly upregulated; relative to the housekeeping gene Human Proteosome subunit Y, however, when the cells were exposed to tumour conditioned media in absence of DMXAA gene expression significantly decreased. Thus, the antitumour action of DMXAA is capable of inhibiting the gene response of TNF-α replicated in a tumour environment.
|
12 |
Telomeres and telomerase in haematopoietic progenitors and bone marrow endothelial cellsSchuller, Christine, Children's Cancer Institute Australia for Medical Research, Faculty of Medicine, UNSW January 2008 (has links)
In normal human somatic cells, the length of telomeres (chromosomal end structures) decreases with each cell division until reaching a critically short length, which halts cell proliferation and induces senescence. The enzyme telomerase, which functions to maintain telomeres at a length that is permissive for cell division, is expressed in approximately 85% of cancer cells and some stem and progenitor cells, including haematopoietic progenitor cells (HPCs), but not most other normal somatic cells. Previous investigations have demonstrated that ectopic expression of telomerase reverse transcriptase (hTERT) reconstitutes telomerase activity, resulting in telomere elongation in some normal human cell types. However, similar experiments performed in HPCs and endothelial cells have demonstrated a dissociation between the expression of telomerase activity and telomere lengthening. This thesis is focussed on further investigating telomerase-mediated telomere length regulation in HPCs and endothelial cells. Short telomeres in bone marrow and blood leukocytes are associated with the development of disorders linked to bone marrow failure. However, to date a relationship between telomere length and myeloid cell proliferative potential has not been demonstrated. In the current investigations, the telomere length and proliferative potential of 31 cord blood-derived HPCs was determined. Regression analysis revealed a significant correlation between mean telomere length and erythroid cell expansion, but not expansion of other myeloid lineage cells. Another novel finding was that telomerase activity was upregulated in lineage-committed CD34- erythroid cells that were positive for the erythroid-specific lineage marker glycophorin A. It was also functionally demonstrated that telomerase activity facilitates the maximum expansion of erythroid cells. To address the dissociation between telomerase activity and telomere maintenance in BMECs, a dominant negative mutant of the telomere binding protein TRF1, which functions to regulate telomere accessibility, was over-expressed in hTERT-transduced BMECs. These studies showed that telomere access, as well as oncogene expression and exposure to oxidative stress, contribute to telomere length regulation in BMECs. Overall, the results from these investigations demonstrate for the first time the functional significance of telomere length and telomerase activity in ex vivo expansion of erythroid cells, and provide novel insight to the molecular complexity of telomere length maintenance in endothelial cells.
|
13 |
Effects of Rosiglitazone on Nitrolgycerin-induced Endothelial DysfunctionPerampaladas, Kumar 06 April 2010 (has links)
Sustained nitroglycerin (GTN) therapy impairs endothelial function in healthy volunteers and patients with cardiovascular disease, caused by an increase in vascular oxidative stress. This study aims to estimate the effect of rosiglitazone on vascular endothelial function in healthy volunteers continuously dosed to transdermal GTN (0.6mg/hr) for 7 days. To assess endothelial function, forearm blood flow was measured by venous occlusion strain-gauge plethysmography in response to intra-brachial infusions of acetylcholine. GTN-treated subjects experienced significant attenuation of endothelium-dependent responses to acetylcholine (p<0.05; compared to placebo), but was reversed with vitamin C (p=ns; compared to placebo). Endothelium-dependent responses to acetylcholine were blunted in groups randomized to rosiglitazone alone (p<0.05; compared to placebo) and rosiglitazone + GTN (p<0.05 compared to placebo). Interestingly, this effect was not modified by vitamin C. In conclusion, rosiglitazone impairs endothelial function and concurrent therapy with rosiglitazone does not attenuate the adverse effects of transdermal GTN on the vasculature.
|
14 |
Examining the Effect of Laminar Flow on Ex Vivo Pancreatic Islet Associated Endothelial CellsCrocker, Alana 17 December 2010 (has links)
Pancreatic islets are heavily vascularized micro-organs containing insulin secreting beta-cells coupled with endothelial cells (EC). These EC slowly deteriorate in static culture, precluding long term study of beta-cell-EC interaction, and likely limiting tissue revascularization post-transplantation. We postulate this EC deterioration is due to an absence of hemodynamics, blood movement. We created a microfluidic device to mimic aspects of hemodynamics, delivering a range of media flow to ex vivo islets. With our resulting desk-top system, we have conducted long term incubations (72 hrs), fixed tissue treatments (maintaining endothelial cell morphology) and real-time live tissue imaging (glucose-stimulated Ca2+-response). Our data show that flow in a microfluidic device maintains EC morphology in ex vivo islets better than non-flowing culture, providing an improved platform to study ex vivo islets and to examine the interaction between beta-cells and EC. Our data also suggest an opportunity to prime islet EC for revascularization using microfluidic flow prior to transplantation.
|
15 |
Effects of Rosiglitazone on Nitrolgycerin-induced Endothelial DysfunctionPerampaladas, Kumar 06 April 2010 (has links)
Sustained nitroglycerin (GTN) therapy impairs endothelial function in healthy volunteers and patients with cardiovascular disease, caused by an increase in vascular oxidative stress. This study aims to estimate the effect of rosiglitazone on vascular endothelial function in healthy volunteers continuously dosed to transdermal GTN (0.6mg/hr) for 7 days. To assess endothelial function, forearm blood flow was measured by venous occlusion strain-gauge plethysmography in response to intra-brachial infusions of acetylcholine. GTN-treated subjects experienced significant attenuation of endothelium-dependent responses to acetylcholine (p<0.05; compared to placebo), but was reversed with vitamin C (p=ns; compared to placebo). Endothelium-dependent responses to acetylcholine were blunted in groups randomized to rosiglitazone alone (p<0.05; compared to placebo) and rosiglitazone + GTN (p<0.05 compared to placebo). Interestingly, this effect was not modified by vitamin C. In conclusion, rosiglitazone impairs endothelial function and concurrent therapy with rosiglitazone does not attenuate the adverse effects of transdermal GTN on the vasculature.
|
16 |
Examining the Effect of Laminar Flow on Ex Vivo Pancreatic Islet Associated Endothelial CellsCrocker, Alana 17 December 2010 (has links)
Pancreatic islets are heavily vascularized micro-organs containing insulin secreting beta-cells coupled with endothelial cells (EC). These EC slowly deteriorate in static culture, precluding long term study of beta-cell-EC interaction, and likely limiting tissue revascularization post-transplantation. We postulate this EC deterioration is due to an absence of hemodynamics, blood movement. We created a microfluidic device to mimic aspects of hemodynamics, delivering a range of media flow to ex vivo islets. With our resulting desk-top system, we have conducted long term incubations (72 hrs), fixed tissue treatments (maintaining endothelial cell morphology) and real-time live tissue imaging (glucose-stimulated Ca2+-response). Our data show that flow in a microfluidic device maintains EC morphology in ex vivo islets better than non-flowing culture, providing an improved platform to study ex vivo islets and to examine the interaction between beta-cells and EC. Our data also suggest an opportunity to prime islet EC for revascularization using microfluidic flow prior to transplantation.
|
17 |
Pharmacological control of human nucleoside transporters in endothelial and cancer cells by emodinLin, Yuen-ting., 林婉婷. January 2012 (has links)
Nucleosides possess many physiological and pharmacological properties. Among nucleosides, adenosine is a particularly important as it regulates many physiological functions in cardiovascular system. For instance, adenosine possesses anti-inflammatory effect through its action on endothelial cells. The functions of adenosine are indirectly controlled by the human equilibrative nucleoside transporters (hENTs). These transporters mediate the uptake of adenosine, thereby reducing the amount of extracellular adenosine available for the adenosine receptors and hence reducing its vascular protective effects. Nucleoside analogs such as gemcitabine, are commonly used as anti-cancer drugs in chemotherapy. Most of the anti-cancer nucleoside drugs require human concentrative nucleoside transporters (hCNTs) for their transport into cancer cells. On the other hand, hENTs is supposed to be responsible for the efflux of anti-cancer nucleoside drugs out of the cancer cells.
In theory, hENT inhibitors should reduce the removal of adenosine from extracellular compartment by endothelial cells and hence increase and prolong the cardioprotective effect of adenosine. hENT inhibitors should also inhibit the efflux of anti-cancer nucleoside drugs, that in turn increases the drug accumulation in the cancer cells, resulting in a higher efficacy. Some typical and clinically used hENT inhibitors have side effects which limit their uses. Emodin, an active ingredient in many herbs, has been proven to have cardioprotective and anti-tumor properties. However, the mechanisms are not fully understood. We hypothesized that these properties may relate to its interaction with nucleoside transporters.
The aims of this study were to investigate the pharmacological effects of emodin on hENTs and its implications on vascular functions and anti-cancer therapy. Our result showed that emodin inhibited both hENT-1 and hENT-2 dose-dependently with no priority to any subtypes of hENTs. The inhibitory effect of emodin on hENTs was reversible and non-competitive, indicating that emodin may interact with the allosteric sites on hENTs. 1,8-dihdroxy-3-methyl anthraquinone, which is similar to emodin in terms of chemical structure but it lacks hydroxyl group at position 3,did not inhibit hENTs. It implied that the presence of 3-hydroxyl group was critical for the inhibitory effect of emodin.
Our result also demonstrated that emodin reduced the lipopolysaccharide-induced expression of adhesion molecule in human umbilical vein endothelial cells, reflecting its anti-inflammatory effect. Emodin also enhanced the cytotoxic effect of gemcitabine in HepG2, a liver cancer cell line. Nevertheless, these effects may not be due to the inhibitory effect of emodin on hENTs and further investigation is required. / published_or_final_version / Pharmacology and Pharmacy / Master / Master of Philosophy
|
18 |
Effect of flavonols on the activity of arginase and the action of nitroglycerin in endothelial cells with and without previous exposure to nitroglycerinJen, Che-lung, 任志龍 January 2014 (has links)
Organic nitrates have been effective treatment for ischemic heart disease for over 100 years. However, there is limitation in their clinical utility since prolonged use of these drugs results in rapid development of nitrate tolerance, which is associated with increased arginase activity and production of reactive oxygen species. Quercetin, a flavonol abundantly found in fruits and vegetables, has been shown to reduce nitrate tolerance in vitro. The objective of this study is to investigate the potential effect of quercetin and three other flavonols (namely, kaempferol, myricetin and rutin) on the development of nitrate tolerance and the activity of arginase in endothelial cells.
Human umbilical vein endothelial cells (HUVECs) were incubated with or without nitroglycerin (GTN) and/or flavonols followed by an acute stimulation with GTN. Level of cyclic guanosine monophosphate (cGMP) released into the cell medium was measured by an enzyme immunoassay. Activity of arginase in cell lysate was measured by a quantitative colorimetric arginase determination assay.
Prior treatment with GTN at 〖10〗^(-5)M for either one or 24 hours did not affect the level of cGMP released from HUVECs induced by subsequent stimulation with GTN. On the other hand, arginase activity was significantly decreased in HUVECs pre-treated with GTN at 〖10〗^(-5)M alone for 24 hours and the decrease was not affected by the concomitant presence of the flavonols during the incubation period. However, the data obtained in HUVECs pre-treated with GTN for 24 hours is questionable due to the lack of a corresponding control (i.e. cells incubating with medium for 24 hours) for proper comparison.
Pre-treatment for one hour with myricetin (〖10〗^(-5) M) and rutin (〖10〗^(-5) M), alone but not in combination with GTN (〖10〗^(-5) M), appears to increase the release of cGMP to subsequent stimulation by GTN (〖10〗^(-5) M). Rutin pre-treatment for one hour also seems to decrease the activity of arginase in HUVECs. However, these effects of myricetin and rutin were significant only when compared to the control group (without pre-treatment with GTN) but not when comparison was made to the vehicle-treated group, while there is no significant difference between the control and the vehicle group in both the cGMP release and arginase activity. As such, these potential effects of myricetin and rutin are inconclusive.
The inability to induce nitrate tolerance in the present experimental condition does not allow further investigation on the potential effect of flavonols on nitrate tolerance. In addition, there are limitations in the present study [namely, lack of corresponding control for the 24 hour incubation groups and small sample size (n = 2-3)]. Therefore, the findings need to be interpreted with cautions; improvements of the present experimental design and increasing the number of experiments are needed in order to obtain more conclusive findings. Future experiments should also be performed in other vascular cells in addition to endothelial cells, as flavonols may exert their beneficial effect in an endothelium-independent manner. / published_or_final_version / Pharmacology and Pharmacy / Master / Master of Medical Sciences
|
19 |
NIR imaging of vascular endothelial cells using Cy5.5-lectin conjugatesNguyen, Cecilia 27 February 2012 (has links)
The objective of this study was to develop a fluorescent near-infrared endothelial cell binding conjugate using Lycopersicon esculentum lectin and Cy5.5 N-hydroxysuccinimide ester for the purpose of imaging the microvascular network in mouse hearts under in vivo and ex vivo conditions. Cy5.5-lectin conjugate was synthesized with a dye/protein ratio of 2.90 ± 1.54 (n=6). Mouse hearts were successfully labelled in both in vivo and ex vivo and showed similar labelling patterns. Cy5.5-lectin labelling patterns and that of ICAM2 and FITC-lectin co-localized, indicating binding to endothelial cells. Finally, it was shown that Cy5.5-lectin is capable of visualizing, in real-time, areas of normal and abnormal heart perfusion at resolutions of 76.8 pixels/mm. Areas of the heart that were not perfused post-ligation displayed no Cy5.5 staining on histological sections and during real-time cardiac imaging of intact hearts showed minimal fluorescent signal (~35 a.u.) compared to areas where normal perfusion occurred (~150 a.u.).
|
20 |
The role of the mesenchyme homeobox genes in the regulation of vascular endothelial cell functionNorthcott, Josette M. D. 10 December 2011 (has links)
The mesenchyme homeobox genes, MEOX1 and MEOX2, encode homeodomain transcription factors. Studies of Meox1/Meox2 knockout mice established that these proteins are partially redundant during development, suggesting that they may regulate common target genes. In the adult vasculature, MEOX2 is expressed in vascular smooth muscle and endothelial cells. MEOX2 has been demonstrated to: i) inhibit proliferation, ii) activate apoptosis and iii) induce senescence. In contrast, the role of MEOX1 has not been studied in the vasculature. Currently, there are two known target genes of MEOX2: cyclin-dependent kinase inhibitor 1A (CDKN1A/p21CIP1/WAF1) and cyclin-dependent kinase inhibitor 2A (CDKN2A/p16INK4a), which regulate transient (quiescent) and permanent (senescent) cell cycle arrest. Senescence is postulated to contribute to the development of atherosclerotic vascular disease by promoting endothelial dysfunction.
We hypothesized that MEOX1 and MEOX2 would activate both p21CIP1/WAF1 and p16INK4a expression, as well as induce apoptosis, cell cycle arrest and senescence in endothelial cells. Furthermore, we postulated that the majority of newly identified MEOX target genes in endothelial cells would be regulated by both MEOX1 and MEOX2.
MEOX proteins were expressed in human endothelial cells via adenoviral transduction. Levels of target gene expression were measured by luciferase reporter gene assays, western blot and quantitative real-time PCR. Electrophoretic mobility shift assays were used to demonstrate MEOX binding to DNA. Cellular proliferation, senescence, and apoptosis were evaluated. For the identification of novel target genes, microarrays were used to compare levels of gene expression in endothelial cells transduced with MEOX constructs or control virus.
Both MEOX1 and MEOX2 activated p21CIP1/WAF1 and p16INK4a gene transcription, inhibited proliferation and induced apoptosis and senescence in endothelial cells. MEOX activation of p21CIP1/WAF1 transcription occurs via a DNA-binding independent mechanism that requires the SP1 transcription factor. In contrast, MEOX activation of p16INK4a transcription is dependent upon DNA-binding. Microarray analysis revealed that both MEOX1 and MEOX2 increased the expression of intercellular adhesion molecule 1 (ICAM-1) and decreased the expression of nitric oxide synthase 3 (NOS3/eNOS).
Taken together, we conclude that MEOX1 and MEOX2 have similar target genes in endothelial cells including p21CIP1/WAF1, p16INK4a and eNOS. As increased endothelial senescence and decreased nitric oxide production are hallmarks of endothelial dysfunction, this study proposes a role for the MEOX proteins in the progression of atherosclerotic vascular disease.
|
Page generated in 0.0696 seconds